NCT04298034View on ClinicalTrials.gov

Preeclampsia Postpartum Antihypertensive Treatment

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions
PreeclampsiaHypertension in Pregnancy
Interventions
DRUG

Labetalol, Nifedipine

Antihypertensive treatment that is safe and well studied in peripartum women.

Trial Locations (1)

53226

Medical College of Wisconsin-Froedtert Hospital, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT04298034 - Preeclampsia Postpartum Antihypertensive Treatment | Biotech Hunter | Biotech Hunter